相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Digital Single-operator Cholangioscopy (DSOC) Improves Interobserver Agreement (IOA) and Accuracy for Evaluation of Indeterminate Biliary Strictures The Monaco Classification
Amrita Sethi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements et al.
JOURNAL OF HEPATOLOGY (2020)
Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma
Hye Sook Han et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
Carolina Reduzzi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound
Wei Jiang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
Ainhoa Lapitz et al.
CELLS (2020)
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
Sakti Chakrabarti et al.
CANCERS (2020)
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach
Jesus M. Urman et al.
CANCERS (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
Yu-Chan Chang et al.
BIOMOLECULES (2020)
The association between circulating MicroRNA-150 level and cholangiocarcinoma
Perihan El Sayed Salem et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma
Phongsaran Kimawaha et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma
Xin-ying Xue et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort
Munirah Alsaleh et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Sven H. Loosen et al.
JHEP REPORTS (2020)
Landscape of circulating tumor DNA and tissue-based profiling in advanced cholangiocarcinoma.
Kabir Mody et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis
Angela Lamarca et al.
JOURNAL OF HEPATOLOGY (2019)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
Diagnostic and prognostic biomarkers in cholangiocarcinoma
Rocio I. R. Macias et al.
LIVER INTERNATIONAL (2019)
Surgery for cholangiocarcinoma
Umberto Cillo et al.
LIVER INTERNATIONAL (2019)
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
Milind M. Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
Ian M. Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma
Majda Haznadar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Bile cell-free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer
Ningjia Shen et al.
ONCOLOGY REPORTS (2019)
Current omics-based biomarkers for cholangiocarcinoma
Kitti Intuyod et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
LBA10_PRClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation
G K Abou-Alfa et al.
ANNALS OF ONCOLOGY (2019)
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Jesus M. Banales et al.
HEPATOLOGY (2019)
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Sven H. Loosen et al.
PLOS ONE (2019)
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study
Marin Strijker et al.
ACTA ONCOLOGICA (2019)
Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas
Ting-Tsung Chang et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma
Bhavya Yarlagadda et al.
NPJ PRECISION ONCOLOGY (2019)
MicroRNAs and extracellular vesicles in cholangiopathies
P. Olaizola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma
Rocio I. R. Macias et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
An elevated expression of serum exosomal microRNA-191,-21,-451a of pancreatic neoplasm is considered to be efficient diagnostic marker
Takuma Goto et al.
BMC CANCER (2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
Alison C. Backen et al.
BRITISH JOURNAL OF CANCER (2018)
Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer
Hideaki Kinugasa et al.
CANCER BIOLOGY & THERAPY (2018)
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
Maeve A. Lowery et al.
CLINICAL CANCER RESEARCH (2018)
Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures
Christian Brooks et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma
Chirag Nepal et al.
HEPATOLOGY (2018)
Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas
Ryuichiro Sawada et al.
HISTOPATHOLOGY (2018)
Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma
Chen-Hai Liu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma
Sumera Rizvi et al.
SEMINARS IN LIVER DISEASE (2018)
Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma
Sudarat Onsurathum et al.
TUMOR BIOLOGY (2018)
Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation
J. Pablo Arnoletti et al.
CANCER BIOLOGY & THERAPY (2018)
miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1
Peiqi Wan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Extracellular Vesicles in Hepatobiliary Malignancies
Ainhoa Lapitz et al.
FRONTIERS IN IMMUNOLOGY (2018)
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Lipika Goyal et al.
CANCER DISCOVERY (2017)
Characterisation of the immune-related transcriptome in resected biliary tract cancers
Michele Ghidini et al.
EUROPEAN JOURNAL OF CANCER (2017)
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial
Loic Verlingue et al.
EUROPEAN JOURNAL OF CANCER (2017)
Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses
Valeria Severino et al.
GASTROENTEROLOGY (2017)
Serum Extracellular Vesicles Contain Protein Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma
Ander Arbelaiz et al.
HEPATOLOGY (2017)
Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma
Henrike Julich-Haertel et al.
JOURNAL OF HEPATOLOGY (2017)
Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma
Sven H. Loosen et al.
JOURNAL OF HEPATOLOGY (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation
Juan Pablo Arnoletti et al.
PANCREAS (2017)
Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group
Runglawan Silakit et al.
PARASITOLOGY INTERNATIONAL (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis
Amir A. Rahnemai-Azar et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis
J. Zhou et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
The diagnostic/prognostic potential and molecular functions of long non-coding RNAs in the exosomes derived from the bile of human cholangiocarcinoma
Xianxiu Ge et al.
ONCOTARGET (2017)
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
Xin Guo et al.
ONCOTARGET (2017)
A panel of microRNA signature in serum for colorectal cancer diagnosis
Mingxia Zhu et al.
ONCOTARGET (2017)
A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
Ji-Guang Han et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2017)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
Sven H. Loosen et al.
SCIENTIFIC REPORTS (2017)
Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
Marek Sierzega et al.
BRITISH JOURNAL OF CANCER (2017)
Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection
Gaya Spolverato et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Ju Dong Yang et al.
HEPATOLOGY (2016)
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
F. Bernuzzi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma
Zhenzhen Liang et al.
DIGESTIVE AND LIVER DISEASE (2016)
Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma
Qun Liang et al.
MOLECULAR BIOSYSTEMS (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma
Xiongbo Wu et al.
TUMOR BIOLOGY (2016)
Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma
Chunbo Zhuang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools
Aitor Esparza-Baquer et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Marta B. Afonso et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma
Camilo Correa-Gallego et al.
PLOS ONE (2016)
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Sven H. Loosen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2016)
Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma
Yong Li et al.
Asian Pacific Journal of Cancer Prevention (2015)
A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma
Jordan Plieskatt et al.
BMC CANCER (2015)
Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study
Adam Slivka et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Probe-based confocal laser endomicroscopy contribution in the evaluation of indeterminate biliary strictures
Domingo Balderramo
GASTROINTESTINAL ENDOSCOPY (2015)
Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review
Udayakumar Navaneethan et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Granulocyte Colony-Stimulating Factor-Producing Cholangiocellular Carcinoma
Kazuhiro Suzumura et al.
INTERNATIONAL SURGERY (2015)
Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection
Bas Groot Koerkamp et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
Torsten Voigtlaender et al.
PLOS ONE (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN
Li-Juan Wang et al.
ONCOTARGET (2015)
Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
Li-Juan Wang et al.
ONCOTARGET (2015)
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma
Qingbao Cheng et al.
SCIENTIFIC REPORTS (2015)
Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Bin Liang et al.
MEDICAL SCIENCE MONITOR (2015)
Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma
Li Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma
Shouli Wang et al.
ONCOLOGY REPORTS (2015)
Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis
Anthony T. Ruys et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma
Amy L. Collins et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Marina Colombo et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
Activating Mutations in PTPN3 Promote Cholangiocarcinoma Cell Proliferation and Migration and Are Associated With Tumor Recurrence in Patients
Qiang Gao et al.
GASTROENTEROLOGY (2014)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
Human Bile Contains MicroRNA-Laden Extracellular Vesicles That Can Be Used for Cholangiocarcinoma Diagnosis
Ling Li et al.
HEPATOLOGY (2014)
Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator
Runglawan Silakit et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
Jeffrey S. Ross et al.
ONCOLOGIST (2014)
Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions
Ali Tuzun Ince et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2014)
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou et al.
NATURE COMMUNICATIONS (2014)
High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery
Ruo-Yu Shi et al.
CANCER (2013)
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Steffen Zender et al.
CANCER CELL (2013)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Extracellular vesicles: Exosomes, microvesicles, and friends
Graca Raposo et al.
JOURNAL OF CELL BIOLOGY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis
P. Chusorn et al.
TUMOR BIOLOGY (2013)
IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications
Darrell R. Borger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
Augusto Villanueva et al.
GASTROENTEROLOGY (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Neoadjuvant Therapy and Liver Transplantation for Hilar Cholangiocarcinoma: Is Pretreatment Pathological Confirmation of Diagnosis Necessary?
Charles B. Rosen et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma
Jian Shen et al.
PLOS ONE (2012)
Proteomic Analysis of Two Types of Exosomes in Human Whole Saliva
Yuko Ogawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in Patients With Hepatocellular Carcinoma or Chronic Hepatitis
Jian Xu et al.
MOLECULAR CARCINOGENESIS (2011)
Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer
Kengo Shigehara et al.
PLOS ONE (2011)
Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
Verena Bihrer et al.
PLOS ONE (2011)
Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia
Anatoliy I. Masyuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma
Kawin Leelawat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy
Amar W. Sharif et al.
HPB (2010)
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy
Kawin Leelawat et al.
BMC GASTROENTEROLOGY (2009)
Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis
N. Albiin et al.
ACTA RADIOLOGICA (2008)
Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma
Takahiro Uenishi et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy
Young Koog Cheon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis
C Levy et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Exosomal-like vesicles are present in human blood plasma
MP Caby et al.
INTERNATIONAL IMMUNOLOGY (2005)
Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells
S Kobayashi et al.
GASTROENTEROLOGY (2005)
Cholangiocarcinoma
KN Lazaridis et al.
GASTROENTEROLOGY (2005)
Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy of Suspected Cholangiocarcinoma
Mohamad A. Eloubeidi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
